Patents

Notice of Allowance for another key patent:

UT09 Vaccine for treatment of obesity, NAFLD and Hypertriglyceridemia

Composition of Matter Patent for UT09 approved by USPTO - 23 Dec 2025

Immunotherapeutic Composition for Prevention of Obesity, Nonalcoholic Fatty Liver Disease and Hypertriglyceridemia, and Methods of use and preparation thereof

Notice of Allowance for another key patent:

UT09 Vaccine for treatment of obesity, NAFLD and Hypertriglyceridemia

Recognized as a

Global Breakthrough in Metabolic Innovation

Utopia Therapeutics was recognized among the Top 5 Innovations at BioAsia 2025, with widespread acclaim in media and scientific communities gaining attention from health innovators, researchers, and policy leaders worldwide.

Follow our journey as we move toward first-in-human trials.

UTOPIA AMONG TOP 5 INNOVATIONS AT BIOASIA 2025

Patents

Notice of Allowance for another key patent:

UT09 Vaccine for treatment of obesity, NAFLD and Hypertriglyceridemia

Composition of Matter Patent for UT09 approved by USPTO - 23 Dec 2025

Immunotherapeutic Composition for Prevention of Obesity, Nonalcoholic Fatty Liver Disease and Hypertriglyceridemia, and Methods of use and preparation thereof

Notice of Allowance for another key patent:

UT09 Vaccine for treatment of obesity, NAFLD and Hypertriglyceridemia

Recognized as a

Global Breakthrough in Metabolic Innovation

Brighten your smile with SmileOn!